Clinical Trials Browser

Phase 1 × ridaforolimus × Plasma cell × Clear all

NCT00060632 2015-08-27

Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

Phase 1 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms

NCT00060645 2015-08-27

Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

Phase 1 Completed

LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Neoplasms